Clinical trial
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
NCT04489225 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
- Lead sponsor
- Medtronic
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 1, 2020
- Completion date
- January 31, 2028
- Enrollment
- 2,200 (estimated)
- Sites
- 92
Conditions
As the registry lists them; a condition with its own page is linked.